Type
. HLA and mycobacterial infection: increased frequency of B8 in Japanese leprosy. Tissue antigens. 1978;11(1):61-4.
Type
. Tuberculosis control in resource-poor countries: alternative approaches in the era of HIV. Lancet (London, England). 1995;346(8976):675-7.
Type
. Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies. American journal of respiratory and critical care medicine. 1995;151(4):1083-6.
Type
. [A very current aspect of the fate of infectious diseases: tuberculosis, leprosy and opportunistic mycobacteria]. Bulletin de l'Academie nationale de medecine. 1995;179(4):805-20; discussion 820-2.
Type
. Recombinant cytokines for controlling mycobacterial infections. Trends in microbiology. 1995;3(1):22-7.
Type
. Use of liposome preparation to treat mycobacterial infections. Immunobiology. 1994;191(4-5):578-83.
Type
. Cytokine regulation of disease progression in leprosy and tuberculosis. Immunobiology. 1994;191(4-5):564-8.
Type
. Prospects for low dose BCG vaccination against tuberculosis. Immunobiology. 1994;191(4-5):548-54.
Type
. Immunoreactive antigens of a candidate leprosy vaccine: Mycobacterium habana. Leprosy review [Internet]. 1995;66(1):31-8. Available from: http://leprev.ilsl.br/pdfs/1995/v66n1/pdf/v66n1a05.pdf
Type
. Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. Immunology letters. 1994;43(1-2):99-107.
Pagination
- Previous page
- Page 58
- Next page